🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

109+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 109 recruiting trials for “Amyotrophic lateral sclerosis

RecruitingNCT07268833

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

🏥 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta📍 4 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06147843

French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis

👨‍⚕️ Philippe COURATIER, Professor, University Hospital, Limoges📍 7 sites📅 Started Sep 2024View details ↗
RecruitingNCT06735014

Multicenter ALS Imaging Study

👨‍⚕️ Pramod Pisharady, PhD, University of Minnesota📍 3 sites📅 Started Sep 2024View details ↗
Enrolling by InvitationNCT06605612

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

🏥 LMU Klinikum📍 1 site📅 Started Sep 2024View details ↗
Phase 1, PHASE2RecruitingNCT06351592

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 16 sites📅 Started Aug 2024View details ↗
NARecruitingNCT06578195

ASSESS ALL ALS Study

👨‍⚕️ ALL ALS Patient Navigator📍 20 sites📅 Started Jul 2024View details ↗
Phase 1Enrolling by InvitationNCT06782958

Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults

👨‍⚕️ Ting Wang, LanZhou University📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06315673

Digital Assessment of Speech and Fine Motor Control in ALS

👨‍⚕️ Andrew Geronimo, PhD📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06280079

Ultra-high-caloric, Fatty Diet in ALS

👨‍⚕️ Johannes Dorst, Prof. Dr., University of Ulm📍 23 sites📅 Started Jun 2024View details ↗
RecruitingNCT06426030

Validation of Czech Language Versions of Questionnaires for ALS Patients' Functional Status and Biomarker Long-term Follow-up

👨‍⚕️ Eva Vlckova, doc,MD,PhD, Masaryk University, University Hospital Brno.📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06219759

Reinnervation and Neuromuscular Transmission in ALS

👨‍⚕️ Jesper H Storgaard, MD, Aarhus University and Department of Neurology, Aarhus University Hospital📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT05983211

Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2

👨‍⚕️ Agessandro Abrahao, Dr., Sunnybrook Health Sciences Centre; University of Toronto📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06453668

A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients

👨‍⚕️ Fredrik Julin, ITB-Med LLC📍 3 sites📅 Started Apr 2024View details ↗
NARecruitingNCT06021938

Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual Reality

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06172621

Spinal Cord Associative Plasticity for ALS

👨‍⚕️ Noam Y. Harel, MD PhD, James J. Peters Veterans Affairs Medical Center📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06765564

Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

🏥 Shanghai East Hospital📍 1 site📅 Started Mar 2024View details ↗
NARecruitingNCT06051123

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

👨‍⚕️ Genevieve Matte, MDCM, FRCP, CRCHUM📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06566651

Emotion Processing Among Patients With ALS

👨‍⚕️ Mia B Heintzelmann, Cand.med, Department of Neurology, Aarhus University Hospital📍 2 sites📅 Started Dec 2023View details ↗
RecruitingNCT06083584

Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis

👨‍⚕️ Claire Guissart, CHU de Nimes📍 7 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT04244630

Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial

👨‍⚕️ Olaf Stuve, M.D., Ph.D., Dallas VA Medical Center📍 1 site📅 Started Nov 2023View details ↗
← PreviousPage 3 of 6Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →